Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Considerations in dosage selection for third generation cephalosporins.

J H Yuk-Choi1, C H Nightingale, T W Williams

  • 1Department of Pharmacy Services, Methodist Hospital, Baylor College of Medicine, Houston, Texas.

Clinical Pharmacokinetics
|February 11, 1992
PubMed
Summary

Third generation cephalosporins require individualized dosing due to varying pharmacokinetics. Optimizing dosage ensures effective treatment by maintaining drug concentrations above minimum inhibitory levels, especially in specific patient populations.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

An Improved Varix Clasp for the Radical Cure of Varicocele.

The Chicago medical journal and examiner·2023
Same author

The differentiation of placoid, ctenoid and cycloid scales by means of alizarin red S.

Stain technology·2010
Same author

Infusion phlebitis: relative incidence associated with cefuroxime administered by intermittent and continuous infusion.

Clinical drug investigation·2008
Same author

A survey of the quality of generic clarithromycin products from 18 countries.

Clinical drug investigation·2007
Same author

In vivo immunomodulatory profile of telithromycin in a murine pneumococcal infection model.

Die Pharmazie·2006
Same author

Intrapulmonary concentrations of telithromycin: clinical implications for respiratory tract infections due to Streptococcus pneumoniae.

Chemotherapy·2005

Area of Science:

  • Pharmacology
  • Infectious Diseases
  • Clinical Pharmacy

Background:

  • Third-generation cephalosporins exhibit diverse pharmacokinetic profiles, necessitating tailored dosing strategies.
  • Their efficacy against aerobic Gram-negative organisms is influenced by a limited post-antibiotic effect, requiring sustained therapeutic concentrations.

Purpose of the Study:

  • To analyze the pharmacokinetic variability of third-generation cephalosporins.
  • To guide optimal dosage regimens considering patient-specific factors and infection sites.

Main Methods:

  • Review of pharmacokinetic data for third-generation cephalosporins.
  • Analysis of factors influencing drug disposition, including protein binding, renal/hepatic function, and patient age.

Main Results:

Related Experiment Videos

  • Pharmacokinetic parameters differ significantly among third-generation cephalosporins.
  • Renal function impacts elimination; hepatic disease generally does not require dose adjustment.
  • Altered protein binding and target site concentrations necessitate dosage modifications.

Conclusions:

  • Individualized dosage adjustment is crucial for third-generation cephalosporins.
  • Consideration of patient-specific factors (renal function, age, disease state) and target site concentrations is essential for optimizing therapeutic outcomes.